Moxibat

Moxibat

moxifloxacin

Manufacturer:

Interbat
Concise Prescribing Info
Contents
Moxifloxacin
Indications/Uses
Adult ≥18 yr w/ bacterial infections eg, acute exacerbations of chronic bronchitis, community acquired pneumonia, acute bacterial sinusitis, complicated skin & skin structure infection; complicated intraabdominal infections. Tab: Adult ≥18 yr w/ bacterial infections eg, acute exacerbations of chronic bronchitis, community acquired pneumonia, acute bacterial sinusitis, complicated skin & skin structure infection; complicated intra-abdominal infections. Mild to moderate pelvic inflammatory disease w/o associated tubo-ovarian or pelvic abscess in combination w/ appropriate antibacterial agent.
Dosage/Direction for Use
400 mg once daily.
Special Precautions
Pseudomembranous colitis, ventricular arrhythmias. Patients w/ CNS disorders, myasthenia gravis, G6PD deficiency, galactose intolerance, Lapp-lactase deficiency or glucose-galactose malabsorption, visual impairment or any effect on the eyes, psychosis or history of psychiatric disease. Concomitant use w/ medication that reduce K & Mg. Discontinue treatment at 1st sign of pain or inflammation, cardiac arrhythmia, symptoms related to liver failure, neuropathy, skin &/or mucosal reactions. Avoid exposure to UV irradiation & extensive sunlight. Maintain adequate fluid intake. Perform liver function tests. May cause false negative Mycobacterium culture test result, dysglycemia. Not recommended for MRSA infections. Patients for whom Na intake is of medical concern (eg, CHF, renal failure, nephrotic syndrome). Not recommended in patients w/ complicated pelvic disease for whom an IV treatment is necessary. May impair ability to drive or operate machinery due to CNS reactions & vision disorders. Women. Elderly.
Adverse Reactions
Mycotic superinfections; headache, dizziness; QT prolongation in patients w/ hypokalemia; nausea, vomiting, GI & abdominal pain, diarrhea; increase in transaminases; inj & infusion site reaction.
MIMS Class
Quinolones
ATC Classification
J01MA14 - moxifloxacin ; Belongs to the class of fluoroquinolones. Used in the systemic treatment of infections.
Presentation/Packing
Form
Moxibat tab 400 mg
Packing/Price
5's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in